USP 37-NF 32

Proposal Status/Commentary

USP posts the status of Revisions, Deferrals, Cancellations, and Commentary for each USP–NF and Supplement.

• Revisions are approved standards that will appear in the publication
• Deferrals are items that have been proposed in Pharmacopeial Forum (PF) but are not yet approved by an Expert Committee
• Cancellations are items that have been proposed in PF but have been canceled. Canceled items may be re-proposed in a future PF
• Commentary is a summary of comments received and the appropriate Expert Committee's responses in cases when proposals advance to official status without being re-published in PF

Revisions, Deferrals, and Cancellations generally are posted in advance of posting of the online USP–NF or Supplement. Commentary is posted the same day the online USP–NF, Supplement, or other official text is released.

Note: The Deferral and Cancellation lists replace the "Previous PF Proposals Still Pending" and "Canceled Proposals" lists that previously appeared in each PF.

USP 37–NF 32

Book

• Revisions (posted 26–Jul–2013)
• Deferrals (posted 26–Jul–2013)
• Cancellations (posted 26–Jul–2013)

IRAs

• IRAs in PF 38 (6)
  • Deferrals: None
  • Cancellations: None
  • Commentary for PF 38 (6)
• IRAs in PF 39 (1)
  • Current Deferrals: Famciclovir
  • Cancellations: None
  • Commentary: No Comments Received
• IRAs in PF 39 (2)
  • Current Deferrals: Oxycodone Hydrochloride Extended-Release Tablets
  • Cancellations: None
  • Commentary: No Comments Received

USP 36–NF 31

Second Supplement

• Revisions (posted 26–Apr–2013)
• Deferrals (posted 26–Apr–2013)
• Cancellations (posted 26–Apr–2013)
• Commentary (posted 03–Jun–2013)

First Supplement

• Revisions (posted 30–Nov–2012)
• Deferrals (posted 30–Nov–2012)
• Cancellations (posted 30–Nov–2012)
• Commentary (posted 01–Feb–2013)

Book

• Revisions (posted 27–Jul–2012)
• Deferrals (posted 27–Jul–2012)
• Cancellations (posted 27–Jul–2012)
• Commentary (posted 01–Nov–2012)

Stage 6 Harmonization (Commentary only)

• No comments received when proposed in Pharmacopeial Forum

IRAs (Commentary only)

• IRAs in 37(6): No comments received for proposed IRAs in Pharmacopeial Forum 37(6)
• IRAs in 38(1): There were no proposed IRAs in Pharmacopeial Forum 38(1)
• IRAs in 38(2): No comments received for proposed IRAs in Pharmacopeial Forum 38(2)
• IRAs in 38(3): (posted 11–Mar–2013)
• IRAs in 38(4): Expert Committee approval pending as of 11–Mar–2013
• IRAs in 38(5): (posted 11–Mar–2013)

USP 35–NF 30 View

USP 34–NF 29 View

USP 33–NF 28 View

USP 32–NF 27 View

USP 31–NF 26 View

USP 30–NF 25 View